LOTRONEX

This brand name is authorized in United States.

Active ingredients

The drug LOTRONEX contains one active pharmaceutical ingredient (API):

`1`	Alosetron UNII `2F5R1A46YW` - ALOSETRON HYDROCHLORIDE
	Alosetron is a potent and selective 5-HT₃ receptor antagonist. 5-HT₃ receptors are ligand-gated cation channels that are extensively distributed on enteric neurons in the human gastrointestinal tract, as well as other peripheral and central locations.
	Read more about Alosetron

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LOTRONEX Tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	54766-894, 54766-895

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.